KoreaMed Synapse

e61

Prognostic impact of reduced tumor-free margin distance on long-term survival in FIGO stage IB/II vulvar squamous cell carcinoma

Leonardo Micheletti, Mario Preti, Viviana Cintolesi, Elisabetta Corvetto, Silvana Privitera, Eleonora Palmese, Chiara Benedetto

KMSID: 1099168 J Gynecol Oncol. 2018;29(5):e61. Published online 2018 April 13 DOI: http://dx.doi.org/10.3802/jgo.2018.29.e61

e64

Burden of cervical neoplasia in mid-western rural Nepal: a population-based study

Niresh Thapa, Girishma Shrestha, Muna Maharjan, Deborah Lindell, Ninu Maskey, Rajiv Shah, Caiyun Ge, Hongbing Cai

KMSID: 1099169 J Gynecol Oncol. 2018;29(5):e64. Published online 2018 April 18 DOI: http://dx.doi.org/10.3802/jgo.2018.29.e64

e65

A triage strategy in advanced ovarian cancer management based on multiple predictive models for R0 resection: a prospective cohort study

Zheng Feng, Hao Wen, Zhaoxia Jiang, Shuai Liu, Xingzhu Ju, Xiaojun Chen, Lingfang Xia, Junyan Xu, Rui Bi, Xiaohua Wu

KMSID: 1099170 J Gynecol Oncol. 2018;29(5):e65. Published online 2018 April 23 DOI: http://dx.doi.org/10.3802/jgo.2018.29.e65

e66

Artificial intelligence weights the importance of factors predicting complete cytoreduction at secondary cytoreductive surgery for recurrent ovarian cancer

Giorgio Bogani, Diego Rossetti, Antonino Ditto, Fabio Martinelli, Valentina Chiappa, Lavinia Mosca, Umberto Leone Roberti Maggiore, Stefano Ferla, Domenica Lorusso, Francesco Raspagliesi

KMSID: 1099171 J Gynecol Oncol. 2018;29(5):e66. Published online 2018 April 23 DOI: http://dx.doi.org/10.3802/jgo.2018.29.e66

e67

Clinical associations of Trousseau's syndrome associated with cerebral infarction and ovarian cancer

Hirokuni Takano, Keiko Nakajima, Yoko Nagayoshi, Hiromi Komazaki, Jiro Suzuki, Hiroshi Tanabe, Shigeki Niimi, Seiji Isonishi, Aikou Okamoto

KMSID: 1099172 J Gynecol Oncol. 2018;29(5):e67. Published online 2018 April 23 DOI: http://dx.doi.org/10.3802/jgo.2018.29.e67

e68

The influence of surgeon volume on outcomes after pelvic exenteration for a gynecologic cancer

Randa J. Jalloul, Alpa M. Nick, Mark F. Munsell, Shannon N. Westin, Pedro T. Ramirez, Michael Frumovitz, Pamela T. Soliman

KMSID: 1099173 J Gynecol Oncol. 2018;29(5):e68. Published online 2018 May 4 DOI: http://dx.doi.org/10.3802/jgo.2018.29.e68

e69

Adequate pelvic lymphadenectomy and survival of women with early-stage epithelial ovarian cancer

Koji Matsuo, Hiroko Machida, Andrea Mariani, Rachel S. Mandelbaum, Gretchen E. Glaser, Bobbie S. Gostout, Lynda D. Roman, Jason D. Wright

KMSID: 1099174 J Gynecol Oncol. 2018;29(5):e69. Published online 2018 May 4 DOI: http://dx.doi.org/10.3802/jgo.2018.29.e69

e70

Negative peritoneal washing cytology during interval debulking surgery predicts overall survival after neoadjuvant chemotherapy for ovarian cancer

Ayaka Iura, Morihito Takita, Aiko Kawano, Kazuaki Imai, Katsuyuki Konnai, Ryo Onose, Hisamori Kato

KMSID: 1099175 J Gynecol Oncol. 2018;29(5):e70. Published online 2018 May 4 DOI: http://dx.doi.org/10.3802/jgo.2018.29.e70

e72

The influence of hormone therapy with drospirenone-estradiol on endometrioid type endometrial cancer patients

Soyi Lim, Yun Hwan Kim, Kwang-Beom Lee, Jong-Min Lee

KMSID: 1099176 J Gynecol Oncol. 2018;29(5):e72. Published online 2018 May 4 DOI: http://dx.doi.org/10.3802/jgo.2018.29.e72

e76

Treatment outcomes of patients with stage II pure endometrioid-type endometrial cancer: a Taiwanese Gynecologic Oncology Group (TGOG-2006) retrospective cohort study

Hung-Chun Fu, Jen-Ruei Chen, Min-Yu Chen, Keng-Fu Hsu, Wen-Fang Cheng, An-Jen Chiang, Yu-Min Ke, Yu-Chieh Chen, Yin-Yi Chang, Chia-Yen Huang, Chieh-Yi Kang, Yuan-Yee Kan, Sheng-Mou Hsiao, Ming-Shyen Yen

KMSID: 1105645 J Gynecol Oncol. 2018;29(5):e76. Published online 2018 May 15 DOI: http://dx.doi.org/10.3802/jgo.2018.29.e76

e77

Efficacy of palonosetron plus dexamethasone in preventing chemotherapy-induced nausea and emesis in patients receiving carboplatin-based chemotherapy for gynecologic cancers: a phase II study by the West Japan Gynecologic Oncology Group (WJGOG 131)

Shin Nishio, Satomi Aihara, Mototsugu Shimokawa, Akira Fujishita, Shuichi Taniguchi, Toru Hachisuga, Shintaro Yanazume, Hiroaki Kobayashi, Fumihiro Murakami, Fumitaka Numa, Kohei Kotera, Naofumi Okura, Naoyuki Toki, Masatoshi Yokoyama, Kimio Ushijima

KMSID: 1099178 J Gynecol Oncol. 2018;29(5):e77. Published online 2018 May 15 DOI: http://dx.doi.org/10.3802/jgo.2018.29.e77

e78

Using low-coverage whole genome sequencing technique to analyze the chromosomal copy number alterations in the exfoliative cells of cervical cancer

Tong Ren, Jing Suo, Shikai Liu, Shu Wang, Shan Shu, Yang Xiang, Jing-He Lang

KMSID: 1099179 J Gynecol Oncol. 2018;29(5):e78. Published online 2018 June 29 DOI: http://dx.doi.org/10.3802/jgo.2018.29.e78

e79

Teenage pregnancy complicated by primary invasive ovarian cancer: association for oncologic outcome

Erin A. Blake, Madushka Y. De Zoysa, Elise B. Morocco, Samantha B. Kaiser, Michiko Kodama, Brendan H. Grubbs, Koji Matsuo

KMSID: 1099180 J Gynecol Oncol. 2018;29(5):e79. Published online 2018 June 27 DOI: http://dx.doi.org/10.3802/jgo.2018.29.e79

e80

Erratum: Prevalence of germline BRCA mutations among women with carcinoma of the peritoneum or fallopian tube

Min Chul Choi, Jin-Sik Bae, Sang Geun Jung, Hyun Park, Won Duk Joo, Seung Hun Song, Chan Lee, Ji-Ho Kim, Ki-Chan Lee, Sunghoon Lee, Je Ho Lee

KMSID: 1099181 J Gynecol Oncol. 2018;29(5):e80. Published online 2018 September 4 DOI: http://dx.doi.org/10.3802/jgo.2018.29.e80

e81

A practical guide to understanding, using and including patient reported outcomes in clinical trials in ovarian cancer

Michelle K. Wilson, Rebecca Mercieca-Bebber, Michael Friedlander

KMSID: 1099182 J Gynecol Oncol. 2018;29(5):e81. Published online 2018 July 9 DOI: http://dx.doi.org/10.3802/jgo.2018.29.e81

e84

Lynch syndrome – Muir-Torre variant: implication in gynecologic oncology

Giorgio Bogani, Umberto Leone Roberti Maggiore, Francesco Raspagliesi

KMSID: 1099183 J Gynecol Oncol. 2018;29(5):e84. Published online 2018 July 23 DOI: http://dx.doi.org/10.3802/jgo.2018.29.e84

e86

Treatment outcomes of high-dose-rate intracavitary brachytherapy for cervical cancer: a comparison of Ir-192 versus Co-60 sources

Thanatip Tantivatana, Kanisa Rongsriyam

KMSID: 1099184 J Gynecol Oncol. 2018;29(5):e86. Published online 2018 July 23 DOI: http://dx.doi.org/10.3802/jgo.2018.29.e86

e80

Erratum: Prevalence of germline BRCA mutations among women with carcinoma of the peritoneum or fallopian tube

Min Chul Choi, Jin-Sik Bae, Sang Geun Jung, Hyun Park, Won Duk Joo, Seung Hun Song, Chan Lee, Ji-Ho Kim, Ki-Chan Lee, Sunghoon Lee, Je Ho Lee

KMSID: 1148313 J Gynecol Oncol. 2018;29(5):e80. Published online 2018 June 20 DOI: http://dx.doi.org/10.3802/jgo.2018.29.e80